Delivery Order SPE2DB24D2205-SPE2DB25FEGEJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Flarex 0.1% eye drops in a 5ML formulation, valued at $6,379.24. This is a firm fixed-price delivery order with no set-aside designation, issued competitively under the company's larger pharmaceutical supply agreement. The order is expected to be completed by August 21, 2025, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $4,510.23 to AmerisourceBergen Drug Corp for Flarex 0.1% eye drops (5mL) on July 23, 2025, with completion expected by July 24, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, regularly...
- The Defense Logistics Agency awarded a delivery order valued at $6,587.60 to AmerisourceBergen Drug Corp for FLAREX 0.1% eye drops (5 mL) on August 5, 2025, with an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The product will be delivered to...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,375.32, is for the delivery of FLAREX 0.1% eye drops in 5ml containers. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 21, 2023. This order is part of AmerisourceBergen's larger Indefinite Delivery Contract...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of FLAREX 0.1% eye drops, a pharmaceutical product. The contract has a ceiling value of $7,347.51 and a period of performance that extends to July 16, 2025. It is a firm-fixed-price contract, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp...
- This is a delivery order for $10,832.68 awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, to provide FLAREX 0.1% eye drops. The contract has a firm fixed price and a completion date of September 26, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which allows the DLA to efficiently procure a comprehensive range of medical commodities, including...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $13,170.83 for FLAREX 0.1% eye drops. The contract has an ultimate completion date of November 14, 2024 and was awarded on November 13, 2024 by the Defense Logistics Agency (DLA), a defense agency. The contract is a Firm Fixed Price type and does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,821.70 delivery order covers the procurement of FLAREX 0.1% eye drops, a specialty ophthalmic medication, with a completion date of December 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a $4,039.03 Firm Fixed Price Delivery Order for the supply of FLAREX 0.1% EYE DROPS 5ML. The contract has an ultimate completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $8,356.51 firm fixed price delivery order is for the supply of FLAREX 0.1% eye drops, a specialty ophthalmic medication. The contract has an ultimate completion date of August 28, 2024. AmerisourceBergen, through its Corporate Office division, has been awarded this order as well as other indefinite delivery contracts (IDCs) by the DLA and Department...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEGEJDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $3,334.12 on August 13, 2025, for Flarex 0.1% eye drops (5mL). This competitive award, which is not set-aside and features firm fixed-price pricing, represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of August 14, 2025. This delivery order falls under AmerisourceBergen's comprehensive pharmaceutical supply agreement with DLA, which is valued at $999,999,999.00 and extends through December 2026. As a major pharmaceutical distributor serving federal medical procurement needs, AmerisourceBergen supplies a broad range of medications, medical devices, and healthcare commodities to military and veteran healthcare systems. This particular order for ophthalmic medication supports the Defense Health Agency and other government healthcare systems that rely on the company's established pharmaceutical distribution capabilities across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 8/13/25 |